{"ticker": {"uuid": "c4807be5-0655-46cd-952d-513bde8587cc", "symbol": "ALOPM", "name": "Oncodesign Precision Medicine Soci\u00e9t\u00e9 anonyme", "exchange": "PAR", "country": "FR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Oncodesign Precision Medicine Announces Equity Financing of up to 5 Million Euros", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQNmNZd2RSeVBQT244WHlzREhFXzR6OFRTTHhLaktMVkxhQV9iYU1ndXJKZ3FNUHp3dk1ldURRdjhoWjF3bVUtQlJVdTZZVnBRMFEySk1sSTQ4am9UNnBJeDBHSDMzbDBYU3k2WjA0TmhpREtBbHpsTmZ6RnJxbnBRNnhoYjBiQUFEdThTM3ZWUUFhMFZwUHJoQ0I5d1g4VFNPRjROWGF3ekZlaDdIUW1uckwyRENGSDluY0dxLVMxU2E4djRXXzRQekJiWTNydm9xNnRDNA?oc=5", "source_name": "Business Wire", "published_at": "2025-04-17T07:00:00+00:00", "published_display": "17 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company's Remaining Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AJBVV95cUxNSlRQcVg1TGFXRFM4ejhubW5rZGlRYmozU01Zazd2VWlNNllqT2NhaWFUVzZKRWRrZm4zSXBCeHFsZUpNb29GSVFBUlNCQmQ1cWJjVFdEYVBnNk9fTlpXZDNxdUNjek9aQkZLWkE2WUdENjYzcHhQT283eW5pS0ptb2pmeEl0Vy1LVUNLcXVQWGZZd0F4SXAxQzU0eTNBOGlLNVFGLVpVemR4OXN1dWUzRW9SRHpkRG1LMU54d0hMZ1diWnFWVC1kRGd6MGcza2RBUC1oNjNkUk1kN2NyVmpjeFdnU0Y2aFUtWG1CZEU0b0RFbkg0NTJHZE9tNjBCU3pqbnJEaVBkRkZsWExQR3JmMUFON2lHX3M5VW5yTF9rMVVha2lJaXk0b2U5Tk53Vk9RVWxseGJBMWJEeHRCeGhMYWJOYndkOVlON3FKVFpTUlVzN1NMcDRIYnlYVmpZcmEySXJVXw?oc=5", "source_name": "Business Wire", "published_at": "2022-10-19T07:00:00+00:00", "published_display": "19 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Wire", "published_at": "2022-07-01T07:00:00+00:00", "published_display": "01 Jul 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Oncodesign Precision Medicine Announces Equity Financing of up to 5 Million Euros", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQNmNZd2RSeVBQT244WHlzREhFXzR6OFRTTHhLaktMVkxhQV9iYU1ndXJKZ3FNUHp3dk1ldURRdjhoWjF3bVUtQlJVdTZZVnBRMFEySk1sSTQ4am9UNnBJeDBHSDMzbDBYU3k2WjA0TmhpREtBbHpsTmZ6RnJxbnBRNnhoYjBiQUFEdThTM3ZWUUFhMFZwUHJoQ0I5d1g4VFNPRjROWGF3ekZlaDdIUW1uckwyRENGSDluY0dxLVMxU2E4djRXXzRQekJiWTNydm9xNnRDNA?oc=5", "source_name": "Business Wire", "published_at": "2025-04-17T07:00:00+00:00", "published_display": "17 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EDMOND DE ROTHSCHILD EQUITY STRATEGIES IV, Advised By ELYAN PARTNERS, Acquires a Majority Stake in ONCODESIGN SERVICES and Will File a Simplified Tender Offer on the Company's Remaining Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AJBVV95cUxNSlRQcVg1TGFXRFM4ejhubW5rZGlRYmozU01Zazd2VWlNNllqT2NhaWFUVzZKRWRrZm4zSXBCeHFsZUpNb29GSVFBUlNCQmQ1cWJjVFdEYVBnNk9fTlpXZDNxdUNjek9aQkZLWkE2WUdENjYzcHhQT283eW5pS0ptb2pmeEl0Vy1LVUNLcXVQWGZZd0F4SXAxQzU0eTNBOGlLNVFGLVpVemR4OXN1dWUzRW9SRHpkRG1LMU54d0hMZ1diWnFWVC1kRGd6MGcza2RBUC1oNjNkUk1kN2NyVmpjeFdnU0Y2aFUtWG1CZEU0b0RFbkg0NTJHZE9tNjBCU3pqbnJEaVBkRkZsWExQR3JmMUFON2lHX3M5VW5yTF9rMVVha2lJaXk0b2U5Tk53Vk9RVWxseGJBMWJEeHRCeGhMYWJOYndkOVlON3FKVFpTUlVzN1NMcDRIYnlYVmpZcmEySXJVXw?oc=5", "source_name": "Business Wire", "published_at": "2022-10-19T07:00:00+00:00", "published_display": "19 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ONCODESIGN Announces the Separation of Its Two Business Lines \u2013 Service and Biotech \u2013 and Its Entry Into Exclusive Negotiations With Elyan Partners for the Sale of a Majority Stake in ONCODESIGN (Service), Followed by a Simplified Takeover Offer", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Wire", "published_at": "2022-07-01T07:00:00+00:00", "published_display": "01 Jul 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 59, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 66, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.34, "latest_week": "2026-07-10", "one_week_move": 2.4, "four_week_move": 0.0, "twelve_week_move": -25.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.514043, "market_dynamics_buy_signal": false, "relative_strength": -28.126746, "fair_value_gap": -64.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 41.4218, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.4% over one week, +0.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Business Wire", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 2}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "66/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.4% over one week, +0.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Oncodesign Precision Medicine Announces Equity Financing of up to 5 Million Euros"}], "updated_at": "2026-07-17T11:43:08.816242+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}